首页> 外文期刊>International Journal of Pharmaceutics >Cubic liquid crystalline structures in diluted, concentrated and highly concentrated emulsions for topical application: Influence on drug release and human skin permeation
【24h】

Cubic liquid crystalline structures in diluted, concentrated and highly concentrated emulsions for topical application: Influence on drug release and human skin permeation

机译:用于稀释,浓缩和高浓度乳液的立方液晶结构,用于局部应用:对药物释放的影响和人体皮肤渗透

获取原文
获取原文并翻译 | 示例
           

摘要

Novel emulsions with a nanostructured continuous phase have been proposed as controlled drug delivery systems to enhance topical delivery of active ingredients avoiding systemic effects. In this study, oil-in-water (O/W) emulsions with two surfactant/water (S/W) weight ratios of 40:60 and 35:65, and oil concentrations of 10 wt% (diluted emulsion), 40 wt% (concentrated emulsion) and 85 wt% (highly concentrated emulsion) have been investigated to identify the presence of liquid crystalline structures and their influence on drug release and skin permeation. The emulsions have been characterized in terms of visual appearance, rheology and drug release. The presence of cubic liquid crystalline structures in emulsions with S/W 40:60 was confirmed by small angle X-ray scattering (SAXS). Rheology results showed a markedly different behaviour in emulsions with S/W 40:60 compared with nonstructured emulsions. A model drug, diclofenac sodium (DS) was successfully incorporated in the emulsions. DS release was studied with hydrophilic and lipophilic membranes, and the amount of DS in the receptor solution was significantly lower in the formulations containing cubic liquid structures. An in vitro skin permeation study with dermatomed human skin showed that emulsions with a nanostructured continuous phase are suitable formulations for topical delivery with DS retention in skin layers. The results indicate that the amount of drug retained in skin structures may be tuned by modification of liquid crystal concentration and emulsion structure.
机译:已经提出了具有纳米结构连续相的新型乳液作为受控药物递送系统,以增强局部递送避免全身效应的活性成分。在该研究中,水 - 水(O / W)乳液,具有两个表面活性剂/水(S / W)的重量比,40:60和35:65,10wt%的油浓度(稀释乳液),40重量%已经研究了%(浓乳液)和85wt%(高浓乳液)以鉴定液晶结构的存在及其对药物释放和皮肤渗透的影响。乳液已经表征在视觉外观,流变和药物释放方面。通过小角度X射线散射(SAX)确认乳液中的立方液晶结构的存在。与非结构化乳液相比,流变结果显示出与S / W 40:60的乳液中具有明显不同的行为。模型药物,双氯芬酸钠(DS)成功掺入乳液中。通过亲水性和亲脂性膜研究DS释放,并且在含有立方液体结构的制剂中,受体溶液中的DS的量显着降低。具有皮肤皮肤皮肤的体外皮肤渗透研究表明,具有纳米结构连续相的乳液是适当的配方,用于局部递送皮肤层的DS保留。结果表明,通过改变液晶浓度和乳液结构,可以调节保留在皮肤结构中的药物量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号